July 01, 2026 a 06:00 pm
MRNA: Fundamental Ratio Analysis - Moderna, Inc.
Moderna, Inc. has emerged as a pivotal player in biotechnology, particularly with mRNA-based therapies. While its innovative pipeline sparks interest, investors should cautiously navigate the current market volatility and the company's valuation metrics.
Fundamental Rating
Moderna currently holds a fundamental rating of 'C'. The company's scores suggest cautious optimism, especially considering its strategic alliances and diverse pipeline.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 1 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
The historical data shows a slight improvement in overall fundamentals, which can be attributed to strategic initiatives and collaborations.
| Date | Overall Score | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2 | 1 | 1 | 1 | 3 | 1 | 3 |
| [Date Unknown] | 0 | 1 | 1 | 1 | 3 | 1 | 3 |
Analyst Price Targets
Analyst forecasts for Moderna suggest a balanced outlook with price targets spanning a wide range.
| High | Low | Median | Consensus |
|---|---|---|---|
| $77 | $33 | $41.5 | $44.88 |
Analyst Sentiment
The sentiment among analysts indicates a majority leaning towards 'Hold', amid diversity in opinion.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 7 | |
| Hold | 16 | |
| Sell | 4 | |
| Strong Sell | 0 |
Conclusion
Moderna, Inc. shows potential growth through its innovative mRNA-based therapies, yet the current market position suggests caution due to valuation metrics. Despite strategic alliances boosting confidence, the mixed analyst sentiment reflects an underlying uncertainty about the near-term trajectory. While investment in Moderna offers strategic gains, it necessitates careful consideration of market fluctuations and valuation constraints.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years